Genetics and heart failure

A concise guide for the clinician

Cécile Skrzynia, Jonathan S. Berg, Monte Willis, Brian C. Jensen

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The pathogenesis of heart failure involves a complex interaction between genetic and environmental factors. Genetic factors may influence the susceptibility to the underlying etiology of heart failure, the rapidity of disease progression, or the response to pharmacologic therapy. The genetic contribution to heart failure is relatively minor in most multifactorial cases, but more direct and profound in the case of familial dilated cardiomyopathy. Early studies of genetic risk for heart failure focused on polymorphisms in genes integral to the adrenergic and renin-angiotensin-aldosterone system. Some of these variants were found to increase the risk of developing heart failure, and others appeared to affect the therapeutic response to neurohormonal antagonists. Regardless, each variant individually confers a relatively modest increase in risk and likely requires complex interaction with other variants and the environment for heart failure to develop.

Dilated cardiomyopathy frequently leads to heart failure, and a genetic etiology increasingly has been recognized in cases previously considered to be “idiopathic”. Up to 50% of dilated cardiomyopathy cases without other cause likely are due to a heritable genetic mutation. Such mutations typically are found in genes encoding sarcomeric proteins and are inherited in an autosomal dominant fashion. In recent years, rapid advances in sequencing technology have improved our ability to diagnose familial dilated cardiomyopathy and those diagnostic tests are available widely. Optimal care for the expanding population of patients with heritable heart failure involves counselors and physicians with specialized training in genetics, but numerous online genetics resources are available to practicing clinicians.

Original languageEnglish (US)
Pages (from-to)10-17
Number of pages8
JournalCurrent Cardiology Reviews
Volume11
Issue number1
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Heart Failure
Dilated Cardiomyopathy
Mutation
Renin-Angiotensin System
Routine Diagnostic Tests
Adrenergic Agents
Genes
Disease Progression
Technology
Physicians
Therapeutics
Population
Proteins

Keywords

  • Cardiomyopathy
  • Dilated
  • Genetic counseling
  • Genetic testing
  • Genetics
  • Heart failure
  • Medical
  • Pharmacogenetics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Skrzynia, C., Berg, J. S., Willis, M., & Jensen, B. C. (2015). Genetics and heart failure: A concise guide for the clinician. Current Cardiology Reviews, 11(1), 10-17.

Genetics and heart failure : A concise guide for the clinician. / Skrzynia, Cécile; Berg, Jonathan S.; Willis, Monte; Jensen, Brian C.

In: Current Cardiology Reviews, Vol. 11, No. 1, 01.12.2015, p. 10-17.

Research output: Contribution to journalArticle

Skrzynia, C, Berg, JS, Willis, M & Jensen, BC 2015, 'Genetics and heart failure: A concise guide for the clinician', Current Cardiology Reviews, vol. 11, no. 1, pp. 10-17.
Skrzynia, Cécile ; Berg, Jonathan S. ; Willis, Monte ; Jensen, Brian C. / Genetics and heart failure : A concise guide for the clinician. In: Current Cardiology Reviews. 2015 ; Vol. 11, No. 1. pp. 10-17.
@article{2faeb8e8482c4c989ff381909ea4a9e4,
title = "Genetics and heart failure: A concise guide for the clinician",
abstract = "The pathogenesis of heart failure involves a complex interaction between genetic and environmental factors. Genetic factors may influence the susceptibility to the underlying etiology of heart failure, the rapidity of disease progression, or the response to pharmacologic therapy. The genetic contribution to heart failure is relatively minor in most multifactorial cases, but more direct and profound in the case of familial dilated cardiomyopathy. Early studies of genetic risk for heart failure focused on polymorphisms in genes integral to the adrenergic and renin-angiotensin-aldosterone system. Some of these variants were found to increase the risk of developing heart failure, and others appeared to affect the therapeutic response to neurohormonal antagonists. Regardless, each variant individually confers a relatively modest increase in risk and likely requires complex interaction with other variants and the environment for heart failure to develop.Dilated cardiomyopathy frequently leads to heart failure, and a genetic etiology increasingly has been recognized in cases previously considered to be “idiopathic”. Up to 50{\%} of dilated cardiomyopathy cases without other cause likely are due to a heritable genetic mutation. Such mutations typically are found in genes encoding sarcomeric proteins and are inherited in an autosomal dominant fashion. In recent years, rapid advances in sequencing technology have improved our ability to diagnose familial dilated cardiomyopathy and those diagnostic tests are available widely. Optimal care for the expanding population of patients with heritable heart failure involves counselors and physicians with specialized training in genetics, but numerous online genetics resources are available to practicing clinicians.",
keywords = "Cardiomyopathy, Dilated, Genetic counseling, Genetic testing, Genetics, Heart failure, Medical, Pharmacogenetics",
author = "C{\'e}cile Skrzynia and Berg, {Jonathan S.} and Monte Willis and Jensen, {Brian C.}",
year = "2015",
month = "12",
day = "1",
language = "English (US)",
volume = "11",
pages = "10--17",
journal = "Current Cardiology Reviews",
issn = "1573-403X",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Genetics and heart failure

T2 - A concise guide for the clinician

AU - Skrzynia, Cécile

AU - Berg, Jonathan S.

AU - Willis, Monte

AU - Jensen, Brian C.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - The pathogenesis of heart failure involves a complex interaction between genetic and environmental factors. Genetic factors may influence the susceptibility to the underlying etiology of heart failure, the rapidity of disease progression, or the response to pharmacologic therapy. The genetic contribution to heart failure is relatively minor in most multifactorial cases, but more direct and profound in the case of familial dilated cardiomyopathy. Early studies of genetic risk for heart failure focused on polymorphisms in genes integral to the adrenergic and renin-angiotensin-aldosterone system. Some of these variants were found to increase the risk of developing heart failure, and others appeared to affect the therapeutic response to neurohormonal antagonists. Regardless, each variant individually confers a relatively modest increase in risk and likely requires complex interaction with other variants and the environment for heart failure to develop.Dilated cardiomyopathy frequently leads to heart failure, and a genetic etiology increasingly has been recognized in cases previously considered to be “idiopathic”. Up to 50% of dilated cardiomyopathy cases without other cause likely are due to a heritable genetic mutation. Such mutations typically are found in genes encoding sarcomeric proteins and are inherited in an autosomal dominant fashion. In recent years, rapid advances in sequencing technology have improved our ability to diagnose familial dilated cardiomyopathy and those diagnostic tests are available widely. Optimal care for the expanding population of patients with heritable heart failure involves counselors and physicians with specialized training in genetics, but numerous online genetics resources are available to practicing clinicians.

AB - The pathogenesis of heart failure involves a complex interaction between genetic and environmental factors. Genetic factors may influence the susceptibility to the underlying etiology of heart failure, the rapidity of disease progression, or the response to pharmacologic therapy. The genetic contribution to heart failure is relatively minor in most multifactorial cases, but more direct and profound in the case of familial dilated cardiomyopathy. Early studies of genetic risk for heart failure focused on polymorphisms in genes integral to the adrenergic and renin-angiotensin-aldosterone system. Some of these variants were found to increase the risk of developing heart failure, and others appeared to affect the therapeutic response to neurohormonal antagonists. Regardless, each variant individually confers a relatively modest increase in risk and likely requires complex interaction with other variants and the environment for heart failure to develop.Dilated cardiomyopathy frequently leads to heart failure, and a genetic etiology increasingly has been recognized in cases previously considered to be “idiopathic”. Up to 50% of dilated cardiomyopathy cases without other cause likely are due to a heritable genetic mutation. Such mutations typically are found in genes encoding sarcomeric proteins and are inherited in an autosomal dominant fashion. In recent years, rapid advances in sequencing technology have improved our ability to diagnose familial dilated cardiomyopathy and those diagnostic tests are available widely. Optimal care for the expanding population of patients with heritable heart failure involves counselors and physicians with specialized training in genetics, but numerous online genetics resources are available to practicing clinicians.

KW - Cardiomyopathy

KW - Dilated

KW - Genetic counseling

KW - Genetic testing

KW - Genetics

KW - Heart failure

KW - Medical

KW - Pharmacogenetics

UR - http://www.scopus.com/inward/record.url?scp=84919683262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919683262&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 10

EP - 17

JO - Current Cardiology Reviews

JF - Current Cardiology Reviews

SN - 1573-403X

IS - 1

ER -